Nervenheilkunde 2009; 28(08): 533-538
DOI: 10.1055/s-0038-1628675
Suchterkrankungen
Schattauer GmbH

Psychotische Störungen durch Alkohol

Alcohol-induced psychotic disorders
M. Soyka
1   Privatklinik Meiringen, Schweiz
› Author Affiliations
Further Information

Publication History

Eingegangen am: 05 December 2008

angenommen am: 09 January 2009

Publication Date:
24 January 2018 (online)

Zusammenfassung

Bei der Alkoholhalluzinose (psychotische Störung durch Alkohol) handelt es sich um ein relativ seltenes Krankheitsbild, das durch die Leitsymptome (akustische) Halluzinationen, Angst und gegebenenfalls Verfolgungswahn bei fehlenden Bewusstseins- und Orientierungsstörungen gekennzeichnet ist. Die wichtigste Differenzialdiagnose ist die Schizophrenie, aber auch das Alkoholdelir sowie drogeninduzierte Psychosen. Die Prognose ist in den meisten Fällen gut, zur Akuttherapie werden Neuroleptika eingesetzt.

Selten sind paranoide Störungen, speziell der alkoholische Eifersuchtswahn, der manchmal als Residuum einer chronischen Alkoholhalluzinose persistiert und monosymptomatisch bleibt. Gefürchtet sind die resultierenden Gewaltdelikte. Die Therapie ist meist schwierig, Neuroleptika nur begrenzt wirksam.

Summary

Alcohol hallucinosis (alcohol-induced psychotic disorders) are a rather disorder characterized by key symptoms such as auditory hallucinations, anxiety and delusions while disorders of consciousness and orientation are missing. The most important differential diagnoses are paranoid schizophrenia, alcohol included delirium and drug-induced psychosis. The prognosis is usually good, for acute treatment neuroleptics can be given.

Alcohol-induced paranoid disorders are rare usually presenting as chronic delusion of jealousy. Violence and aggression may present and the prognosis is poor.

 
  • Literatur

  • 1 Aliyev ZN, Aliyev NA. Valproate treatment of acute alcohol hallucinosis: a double-blind, placebo-controlled study. Alcohol 2008; 43: 456-459.
  • 2 Benedetti G. Die Alkoholhalluzinose. Stuttgart: Thieme; 1952
  • 3 Borg S, Kvande H, Valverius P. Clinical conditions and central dopamine metabolism in alcoholics during acute withdrawal under treatment with different pharmacological agents. Psychopharmacology 1996; 88: 12-17.
  • 4 Burton-Bradley BG. Aspects of alcoholic hallucinoses. Med J Australia 1958; 02: 8-11.
  • 5 Cutting J. A re-appraisal of alcoholic psychoses. Psychol Med 1978; 08: 285-295.
  • 6 De Millas W, Haasen C. Treatment of alcohol hallucinosis with Risperidone. Am J Addict 2007; 16: 249-250.
  • 7 Fodstad Untersuchungen zur Frage der Alkoholpranoia: Beitrag zur Deutung der somatogenen Psychose. Schweiz Arch Neurol.Neurochir Psychiat 1968; 102: 432.
  • 8 Glass IB. Alcoholic hallucinosis: a psychiatric enigma. 1. The development of an idea. Br J Addict 1989; 84: 29-41.
  • 9 Glass IB. Alcohol hallucinosis: a psychiatric enigma. 2. Follow-up Studies. Br J Addict 1989; 84: 151-164.
  • 10 Hiemke Baumann P. Spezielle Arzneimittel-Interaktionen. In: Holsboer F. et al. (Hrsg) Handbuch der Psychopharmakotherapie. Heidelberg: Springer; 2008: 1127-1144.
  • 11 Hrubec Z, Omenn GS. Evidence of genetic disposition to alcoholic cirrhosis and psychosis: Twin concordances for alcoholism and its biological end points by zygosity among male veterans. Alcohol Clin Exp Res 1981; 05: 207-215.
  • 12 Jensen GB, Pakkenberg B. Do alcoholics drink their neurons away?. Lancet 1993; 342: 1201-1204.
  • 13 Kendler KS. A twin study of individuals with both schizophrenia and alcoholism. Brit J Psychiatry 1985; 147: 48-53.
  • 14 Kendler KS, Gruengerg AM, Tsuang MT. Psychiatric illness in first degree relatives of schizophrenic and surgical control patients. Arch Gen Psychiatry 1985; 42: 8770-779.
  • 15 Kitabayashi Y. et al. Neuropsychiatric background of alcohol hallucinosis: a SPECT study. J Neuropsychiatry Clin Neurosci 2007; 19: 85.
  • 16 Laux G, Reimer F. Zur Pathogenese des alkoholischen Eifersuchtswahns. Nervenarzt 1979; 50: 299-301.
  • 17 Marcel LNS. De la folie causee par l`abus des boissons alcooliques, thesis. Paris, Imprimeur de la Faculté de Médecin. Rinoux. 1847
  • 18 Mooney H. Pathologic jealousy and psychochemotherapy. Br J Psychiatry 1965; 111: 1023-1042.
  • 19 Pollock BG. Successful treatment of pathological jealousy with pimozide. Can J Psychiatry 1982; 27: 86-87.
  • 20 Rommelspacher H. et al. Plasma norharman (beta-Carboline) levels are elevated in chronic alcoholics. Alcohol Clin Exp Res 1991; 15: 553-559.
  • 21 Schilkrut R. et al. Neuroleptics in the treatment of drug dependence in schizophrenics: A study with flupenthixol decanoate. Psychopharmacology 1988; 96 (Suppl): 342 (Abstract No. 33.01.50).
  • 22 Schuckit MA, Winokur G. Alcoholic hallucinosis and schizophrenia: A negative study. Brit J Psychiatry 1971; 119: 549-550.
  • 23 Scott D. Alcoholic hallucinosis – an aetiological study. Brit J Addict 1967; 62: 113-125.
  • 24 Scott D. et al. Alcoholic hallucinosis. Int J Addict 1969; 04: 319-330.
  • 25 Soyka D, Soyka M. Eifersucht und Eifersuchtswahn als Motiv bei Tötungsdelikten – forensische und psychiatrische Aspekte. Psychiatr Praxis 1996; 23: 131-134.
  • 26 Soyka M. Sucht und Schizophrenie. 1. Alkoholismus und Schizophrenie. Fortschr Neurol Psychiatr 1994; 62: 71-87.
  • 27 Soyka M. Das Othello-Syndrom. Eifersucht und Eifersuchtswahn als Symptom psychischer Störungen. Fortschr Neurol Psychiatr 1995; 63: 487-494.
  • 28 Soyka M. Die Alkoholhalluzinose – Pathophysiologie, Klinik und Therapie. Nervenarzt 1996; 67: 891-895.
  • 29 Soyka M. Optimierte Arzneimitteltherapie: Alkoholabhängigkeit. Berlin: Springer; 1999
  • 30 Soyka M. et al. PET and SPECT findings in alcohol hallucinosis: Case report and super-brief review of the pathophysiology of this syndrome. World J Biol Psychiatry 2000; 01: 215-218.
  • 31 Soyka M, Botschev C, Völcker A. Neuroleptic treatment in alcohol hallucinosis: no evidence for increased seizure risk. J Clin Psychopharmacol 1992; 12 (01) 66-67.
  • 32 Soyka M, Koch W, Tatsch K. Thalamic hypofunction in alcohol hallucinosis: FDG PET findings. Psychiatry Res 2005; 139: 259-202.
  • 33 Soyka M. et al. Guidelines for biological treatment of substance use and related disorders, part 1: Alcoholism. World J Biol Psychiatry 2008; 09: 6-23.
  • 34 Soyka M, Küffner H. Alkoholismus – Missbrauch und Abhängigkeit. Stuttgart: Thieme; 2008
  • 35 Soyka M, Naber G, Völcker A. Prevalence of delusional jealousy in different psychiatric disorders – an analysis of 93 cases. Br J Psychiatry 1991; 158: 549-553.
  • 36 Soyka M. Prevalence of alcohol-induced psychotic disorders. Eur Arch Psychiat Clin Neurosci 2008; 258: 317-318.
  • 37 Soyka M, Sand P. Successful treatment with flupenthixol decanoate of a patient with both schizophrenia and alcoholism. Pharmacopsychiatry 1995; 28: 64-65.
  • 38 Soyka M, Saß H, Völcker A. Der alkoholische Eifersuchtswahn – psychopathoplogische Charakteristika zweier Verlaufstypen. Psychiatr Praxis 1989; 16: 189-193.
  • 39 Soyka M, Wegner U, Moeller HJ. Risperidone in treatment-refractory chronic alcohol hallucinosis. Pharmacopsychiatry 1997; 30: 135-136.
  • 40 Soyka M. et al. FDG-PET and IBZM-SPECT suggest reduced thalamic activity but no dopaminergic dysfunction in chronic alcohol hallucinosis (letter). J Neuropsychiatry Clin Neurosci 2000; 12: 287-288.
  • 41 Spitzer JB. Auditory Effects of Chronic Alcoholism. Drug Alcohol Depend 1981; 08: 317-335.
  • 42 Surawicz FG. Alcoholic hallucinosis: a missed diagnosis. Can J Psychiatry 1980; 25: 57-63.
  • 43 Tsuang JW. et al. Characteristics of men with alcoholic hallucinosis. Addiction 1994; 89: 73-78.
  • 44 Victor M, Hope HM. The phenomenon of auditory hallucinations in chronic alcoholism: a critical evaluation of the status of alcoholic hallucinosis. J Nerv Ment Dis 1958; 126: 451-481.
  • 45 Mann K. et al. The reversibility of alcohol brain damage is not due to rehydration: A CT study. Addiction 1993; 88: 649-653.
  • 46 Mann K. et al. Neuroimaging in alcoholism: Ethanol and brain damage. Alcohol Clin Exp Res 2001; 25: 104-109.
  • 47 Fabricing K. et al. No changes in neocortical cell volumes or glial cell numbers in chronic alcoholic subjects compared to control subjects. Alcohol 2008; 42: 400-406.
  • 48 Soyka M. Pharmacological treatment of alcohol hallucinosis. Alcohol 2008; 43: 719-720.